Britain’s £1 Billion Supplement Habit: What Works, What’s Hype and Which Experts Take What

Table of Contents

1. Key Highlights:
2. Introduction
3. Why Britain’s supplement market exploded
4. What the science reliably supports — and what remains speculative
5. What top clinicians actually take — and why their routines matter
6. Safety, interactions and the limits of self-prescribing
7. Regulation, marketing and the celebrity effect
8. Practical, evidence-based pathways for common goals
9. How to choose a supplement — a practical checklist
10. Cost, convenience and environmental considerations
11. Common myths and red flags to ignore
12. A sensible supplementation roadmap you can follow
13. Real-world examples
14. Where the evidence needs to improve
15. FAQ

Key Highlights:

• The UK supplement market now exceeds £1 billion annually, driven by targeted formulas, celebrity brands and social media influence; evidence supports a handful of nutrients (vitamin D, iron, B12, magnesium) for specific groups.
• Leading clinicians take only a small set of supplements tailored to measurable needs; indiscriminate use and high-dose stacking pose risks and rarely deliver promised benefits.
• A practical approach—test before you top up, prioritise diet, choose reputable products and monitor for interactions—maximises benefit and limits waste.

Introduction

Supplements have moved from the medicine cabinet into mainstream life. Once confined to cod liver oil and vitamin C, the market now sells targeted stacks for sleep, mood, skin, brain health and longevity. Supermarket shelves and social feeds offer powders, gummies and bespoke blends that promise sharper thinking, stronger bones and even a longer life. Consumers have responded: the sector is estimated to grow about 8% year-on-year and now generates more than £1 billion in the UK.

The growth raises a practical question: which products genuinely improve health, and which simply sell a story? Researchers and clinicians acknowledge that certain supplements improve outcomes when used for real deficiencies or in high-risk groups. Yet much of the industry leans on marketing and selective science. This article synthesises what researchers and leading UK clinicians actually recommend, the strongest evidence for common supplements, the safety and regulatory concerns every buyer should know, and a step-by-step plan for deciding whether and how to supplement responsibly.

Why Britain’s supplement market exploded

Several forces explain the rapid expansion of supplement sales:

• Demographics and ageing: An older population is more concerned about bone health, cognitive decline and chronic disease prevention. Products promising “longevity” and joint support attract older consumers.
• Lifestyle realities: Busy lives, restrictive diets, and less time outdoors have left measurable gaps in nutrient status for many people—vitamin D deficiency is common in the UK, for example—creating an appetite for easy fixes.
• Celebrity and influencer amplification: High-profile endorsements and A-list product launches turn vitamins into fashion items. Collagen from TV presenters and wellness brands fronted by actors bring attention and sales.
• Marketing precision: Manufacturers now sell targeted formulas (brain, hormones, sleep), making supplements feel personalised and solving a perceived problem.
• Rising health literacy and preventive care: People are increasingly proactive about health, seeking tools beyond conventional medicine to preserve quality of life.

Retailers confirm the shift. Chains such as Holland & Barrett report growing demand in categories like magnesium and joint support. Some clinicians recognise benefits where deficiency or clear clinical need exists; others warn that many products provide no measurable advantage and may distract from better interventions.

What the science reliably supports — and what remains speculative

The strength of evidence varies widely by nutrient and condition. Below are the most commonly discussed supplements and a balanced assessment of the data that matters to consumers.

Vitamin D

• What it does: Supports bone mineralisation, calcium homeostasis and aspects of immune function.
• Evidence: Widespread low levels in northern climates make supplementation sensible for many, particularly through autumn and winter. Observational links exist between low vitamin D and poorer outcomes in some cancers and infections; some randomised data suggest benefits for bone health and fall prevention in older adults.
• Who benefits: People with low measured levels, older adults, those who get little sun exposure, people with darker skin, and those with malabsorption.
• Safety: Toxicity is rare at recommended doses but rises with high, unsupervised intake. Vitamin D supplements often pair with vitamin K2 to support calcium distribution.

Iron

• What it does: Essential for haemoglobin, oxygen transport and cellular metabolism.
• Evidence: Clear benefit when iron deficiency or iron-deficiency anaemia is present. A study cited in the source indicates iron supplementation reduced hospitalisation and death in people with heart failure; iron replacement is also known to relieve fatigue and cognitive symptoms in deficient individuals.
• Who benefits: Women of reproductive age, pregnant people, those with heavy menstrual bleeding, people with malabsorption (coeliac disease), vegetarians and vegans who don’t get sufficient iron from diet.
• Safety: Excess iron causes toxicity and can worsen conditions like haemochromatosis. Blood tests should guide dosing.

Vitamin B12 and methylated B complexes

• What they do: Support red blood cell production, neurological function and methylation reactions.
• Evidence: Deficiency causes neuropathy and anaemia. Older adults, vegans and people with absorption issues benefit from supplementation. Methylated forms (methylcobalamin) are useful for those with certain genetic polymorphisms affecting methylation.
• Who benefits: Older adults, strict vegetarians/vegans, people on metformin or proton pump inhibitors, those with absorption disorders.

Magnesium

• What it does: Cofactor for hundreds of enzymatic reactions; involved in muscle and nerve function, sleep regulation and energy production.
• Evidence: Certain formulations (magnesium glycinate) can improve sleep in people with insomnia and help muscle cramps. Evidence for general population supplementation is mixed, but people with low intake or specific complaints may benefit.
• Who benefits: People with poor dietary intake, athletes with high losses, those with sleep disturbances or muscle cramps.
• Safety: High doses can cause diarrhoea; kidney impairment raises toxicity risk.

Omega-3 fatty acids (EPA/DHA)

• What they do: Anti-inflammatory effects, roles in cardiovascular and cognitive health.
• Evidence: Long-chain omega-3s lower triglycerides. Large trials on cardiovascular outcomes show mixed results; benefits are clearer for certain high-risk groups. Evidence for cognitive decline prevention is limited and inconsistent.
• Who benefits: People with low oily fish intake, those with hypertriglyceridaemia; discussion with a clinician recommended for cardiovascular use.
• Safety: May interact with anticoagulant therapy at high doses.

Coenzyme Q10 (CoQ10)

• What it does: Key role in mitochondrial energy production and antioxidant defence.
• Evidence: Some trials suggest benefit in heart failure and for people experiencing statin-associated muscle symptoms. The quality of evidence varies; clinical guidance often supports considering CoQ10 in specific cardiac contexts.
• Who benefits: Patients with heart failure, some on statins who have muscle symptoms.
• Safety: Generally well tolerated.

Creatine

• What it does: Supports ATP regeneration in high-energy-demand tissues such as muscle and brain.
• Evidence: Robust for improving muscle mass and strength in conjunction with resistance training. Emerging evidence shows cognitive benefits in some groups (older adults, sleep-deprived individuals, vegetarians) and potential neuroprotective roles.
• Who benefits: Older adults to preserve muscle mass, athletes, and possibly people seeking cognitive support.
• Safety: Considered safe at typical doses; hydration and renal monitoring recommended if kidney disease is present.

Nicotinamide (vitamin B3)

• What it does: Precursor of NAD+ with roles in DNA repair and inflammation.
• Evidence: Randomised trials have shown topical nicotinamide can reduce certain skin cancers in high-risk individuals; systemic effects are an area of ongoing research.
• Who benefits: People at high risk of non-melanoma skin cancers may gain from topical or oral nicotinamide under medical advice.

Nicotinic compounds (nicotine)

• What it does: Agonist at nicotinic acetylcholine receptors; implicated in dopamine signalling.
• Evidence: Observational data suggest smokers had lower Parkinson’s rates in some cohorts. Researchers hypothesise nicotine may modulate pathways relevant to Parkinson’s disease. The signal is preliminary and observational; nicotine carries addiction and cardiovascular risks when used in higher doses or tobacco form.
• Who benefits: Not established; experimental low-dose nicotine lozenges are under study but should not be adopted widely without medical supervision.

Collagen and “beauty” stacks

• What they do: Supply amino acids for connective tissue; products often claim to improve skin elasticity and hair.
• Evidence: A handful of small studies suggest modest improvements in skin elasticity and hydration with hydrolysed collagen peptides, but many marketed formulas lack robust clinical data. Dermatologists caution that overall protein and nutrient sufficiency, sun protection and topical treatments remain stronger evidence-based approaches.
• Who benefits: Marginal gains might occur; not a replacement for established skin cancer prevention strategies or topical medical treatments.
• Safety: Generally safe but costly and not a panacea.

Herbal and mushroom supplements (ashwagandha, lion’s mane, cordyceps, reishi)

• What they do: Diverse traditional uses—stress modulation, cognitive support, immune modulation.
• Evidence: Some small trials show benefits (ashwagandha for stress, certain mushrooms for immune markers and mild cognitive effects), but heterogeneity in formulations and study quality limits generalisation.
• Who benefits: People seeking adjunctive support may find subjective improvements; robust clinical recommendations are limited.
• Safety: Potential for interactions with medications and variability in product purity.

Multivitamins and longevity claims

• What it does: Broad micronutrient coverage.
• Evidence: Some trials suggest multivitamin use modestly affects biomarkers and may slow aspects of biological ageing in older adults; evidence for extending lifespan remains limited. Where diets are poor or absorption impaired, multivitamins can correct deficiencies.
• Who benefits: Older adults, people with poor diets, certain at-risk groups.
• Cost-benefit: Some trials frame multivitamin use as inexpensive relative to potential benefit—the source article cites an estimate of about 5p a day for one study’s intervention.

Calcium

• What it does: Structural bone component and cellular signalling.
• Evidence: Adequate calcium intake with vitamin D supports bone health. Over-supplementation without need may increase cardiovascular risk in some studies; dietary calcium is preferred.
• Who benefits: Postmenopausal women and others who cannot meet intake through diet.
• Safety: Balance with vitamin D and avoid chronic high-dose calcium unless medically indicated.

Zinc

• What it does: Immune function, protein synthesis and wound healing.
• Evidence: Short-term zinc can reduce duration of viral illness when started early; evidence is mixed for chronic prophylactic use. Deficiency causes immune dysfunction.
• Who benefits: People with inadequate dietary intake or deficiency; some clinicians take zinc seasonally.

Copper

• What it does: Cofactor in enzymatic reactions and iron metabolism.
• Evidence: Needed in small amounts; usually provided in multivitamins. High zinc intake can cause copper deficiency; balancing trace minerals matters.

The pattern is clear: certain nutrients have strong, condition-specific evidence and clear indications for testing and replacement. Many other products show mixed or preliminary findings; consumers should be alert to marketing that overstates benefits.

What top clinicians actually take — and why their routines matter

Clinicians who study and treat the conditions targeted by supplements generally adopt a restrained, evidence-led approach. They use blood tests, symptom patterns and clinical context to decide which products to use. The following summaries reflect a cross-section of UK specialists and the rationale behind their personal choices.

Professor Sophie Scott — Neuroscientist

• Routine: Iron (in a multivitamin), magnesium glycinate for sleep; experimenting with low-dose nicotine lozenges; considering creatine.
• Rationale: Iron corrects anaemia that interferes with cognitive tasks and energy. Magnesium glycinate helps sleep and muscle relaxation; trials support magnesium for insomnia. Nicotine is being explored for a possible mild preventative effect in Parkinson’s disease based on observational links between smoking and reduced Parkinson’s incidence; Professor Scott uses low-dose lozenges cautiously. Creatine shows emerging cognitive benefits in some studies and is favoured by some neuroscientists.

Professor Annice Mukherjee — Endocrinologist (hormonal health)

• Routine: Vitamin D year-round, a general multivitamin, occasional calcium gummies.
• Rationale: Vitamin D supports bone health and immune function; deficiency is common in the UK. A multivitamin compensates for imperfect diets and stresses that may impair absorption. Calcium is used as-needed; many people don’t meet daily requirements through diet alone.

Dr Ash Kapoor — Longevity specialist

• Routine: Intensive stack (reported 16 supplements daily) including cordyceps, creatine, methylated B complex, vitamin D3/K2, omega blend, multivitamin, CoQ10, lion’s mane, zinc, copper, magnesium, reishi, ashwagandha.
• Rationale: An aggressive, targeted approach aimed at optimising energy, immunity, cognitive function and sleep. His regimen is paired with lifestyle interventions: daily exercise, periodic fasting and breathwork. Dr Kapoor emphasises supplements as adjuncts, not substitutes, for a whole-food diet and minimal processed foods.

Professor Tess McPherson — Dermatologist

• Routine: Zinc during winter, vitamin D for osteoporosis, magnesium at night; considering nicotinamide.
• Rationale: Zinc supports immune defence against viral illnesses and may lessen severity. Vitamin D was started after a diagnosis of osteoporosis. Magnesium aids sleep and muscle function. She rejects many commercial skin- and hair-focused blends (collagen powders etc.) that lack strong evidence.

Professor Hendrik-Tobias Arkenau — Oncologist

• Routine: Vitamin D.
• Rationale: Vitamin D supports bone health and immune regulation; some data link higher vitamin D to better cancer-related outcomes and tolerability of treatment. He otherwise relies on clinical monitoring and targets supplementation to deficiencies.

Dr Fozia Ahmed — Cardiologist

• Routine: Low-dose iron (~20 mg), vitamin D; observing CoQ10 evidence.
• Rationale: Iron deficiency is widely underdiagnosed in women and harms cardiovascular performance. Treating mild deficiency improves symptoms and supports the cardiovascular system. Vitamin D is used for bone and immune support. CoQ10 is on her radar for heart-related benefits in specific patient groups.

Their common themes:

• Testing guides treatment. None habitually take megadoses without evidence of deficiency or clinical need.
• Supplements are adjuncts. Lifestyle, diet, sleep and exercise are primary.
• They recognise the influence of marketing and use critical appraisal to distinguish plausible interventions from hype.

Safety, interactions and the limits of self-prescribing

Supplements are not harmless by default. Several safety and practical considerations must guide use.

1. Blood tests first

• Check vitamin D, iron studies (ferritin, haemoglobin), B12 and folate when suspecting deficiency. Tests prevent unnecessary dosing and avoid toxicity.

2. Drug–nutrient interactions

• Vitamin K affects warfarin; large omega-3 doses can alter bleeding risk; high zinc interferes with copper absorption; some herbal products interact with prescription drugs (e.g., St John’s wort).
• Always review supplements with anyone prescribing medications or managing chronic conditions.

3. Megadoses and chronic use

• Prolonged high-dose vitamin A, selenium, iron or vitamin E can cause harm. Avoid “more is better” thinking.
• Trace elements require balance; supplementing one mineral often affects others.

4. Quality and contamination

• Supplements are classified as foodstuffs, not medicines, so regulatory standards differ. Product purity, accurate dosing and contamination vary between brands.
• Choose manufacturers with third-party testing and transparent batch analysis.

5. Addiction and nicotine

• Nicotine lozenges deliver an addictive compound that carries cardiovascular and dependency risks; experimental use should be medicalised and cautious.

6. Allergens and added ingredients

• Gummies and powders may contain sugar, artificial colours, allergens or excipients; read labels.

7. Vulnerable groups

• Pregnant people: avoid high-dose vitamin A and certain herbs; follow obstetric guidance. Children: many adult formulations are inappropriate. Renal impairment: dosing needs specialist advice.

Regulation, marketing and the celebrity effect

The market’s credibility problem stems partly from regulatory reality and marketing tactics.

• Regulation: In the UK, supplements are regulated as foods. Manufacturers must meet safety standards but do not undergo the rigorous pre-market approval demanded of drugs. Claims about treating disease are prohibited, yet phrasing and lifestyle claims can imply therapeutic benefit.
• Claims versus evidence: Health claims are often based on selective trials, in vitro studies, or small sample sizes. Consumers may see persuasive narratives without critical trial context.
• Celebrity brands and influencers: Celebrity-endorsed lines and influencer content normalise supplementation and propel trends. This drives sales but does not equate to evidence. Clinicians often see patients influenced by marketing, sometimes seeking prescriptions or tests to justify popular regimens.
• Third-party verification: Independent testing (such as NSF, USP, Informed-Sport) reduces risk of contamination and mislabelling; look for certificates rather than glossy marketing.

Practical, evidence-based pathways for common goals

Many people take supplements for specific outcomes: bone health, energy, sleep, cognitive support and immune resilience. Below are practical steps for each goal, emphasising testing, diet and targeted supplementation.

Bone health and fracture prevention

• Start with a diet assessment: calcium-rich foods (dairy or fortified alternatives), weight-bearing exercise, smoking cessation and adequate protein.
• Test vitamin D and consider supplementation if levels are low or if sun exposure is limited. Combine with calcium where dietary intake is insufficient.
• Postmenopausal women and people with osteoporosis require clinical management; supplements are adjuncts to medical therapy when indicated.

Fatigue and low energy

• Rule out anaemia with ferritin and haemoglobin testing; correct iron deficiency under supervision.
• Check B12 and thyroid function. Treat deficiencies rather than indiscriminately stacking stimulatory supplements.
• Consider small dietary changes and sleep hygiene before initiating complex stacks.

Sleep and mood support

• Magnesium glycinate has clinical support for improving sleep in people with insomnia.
• Ashwagandha shows modest evidence for stress reduction; quality control of herbal products is essential.
• Avoid stimulant-containing blends before bed; review prescription medications and caffeine intake.

Cognitive maintenance and brain health

• Test B12 and correct deficiency promptly.
• Creatine supplementation shows promising cognitive benefits in some groups; evidence is evolving.
• Omega-3 benefits for cognition are inconsistent; dietary fish intake remains a reasonable first step.

Cardiovascular health

• Address established risk factors: blood pressure, lipids, smoking, activity and diet.
• Omega-3 supplementation helps triglyceride management. CoQ10 can be considered in heart failure or statin intolerance scenarios; discuss with cardiology.
• Iron supplementation for iron-deficiency heart failure has demonstrated benefit in certain trials; specialist guidance is necessary.

Skin and hair claims

• Prioritise sun protection and dermatological advice for skin cancer prevention and treatments.
• Nicotinamide may reduce non-melanoma skin cancer risk in high-risk individuals under medical supervision.
• Skepticism is warranted for many marketed collagen and beauty blends; small improvements may exist, but they do not replace clinical prevention and treatment.

Longevity and anti-ageing

• Evidence for supplements extending lifespan remains limited. Small shifts in biomarkers have been reported for some interventions, but translating that to years of healthy life requires more robust data.
• Clinically prioritise modifiable lifestyle factors: exercise, smoking cessation, balanced diet, sleep and management of chronic disease.
• If considering a longevity-focused stack, have a clear rationale, monitor markers and involve a clinician.

How to choose a supplement — a practical checklist

1. Test first where feasible: vitamin D, ferritin, B12.
2. Define the specific goal: correct deficiency, treat a symptom, or general insurance?
3. Review the evidence: small clinical trials, large RCTs, or only marketing claims?
4. Check for interactions with medications.
5. Start with single-ingredient products rather than proprietary blends when possible.
6. Prefer third-party tested products and transparent manufacturers.
7. Keep dosing conservative; follow medical advice for higher-dose therapies.
8. Reassess after a defined period—are symptoms improved? Have blood markers normalized?
9. Avoid lifetime use without periodic review, especially for high-dose or multiple supplements.

Cost, convenience and environmental considerations

Supplements are a significant household expense. The UK market exceeds £1 billion, and individuals’ costs vary widely. One multivitamin strategy is sometimes framed as an inexpensive preventive measure (the source article cited an estimated cost of about 5p a day for a trial intervention). High-end niche brands and celebrity lines often carry substantial markups.

Environmentally, some supplements rely on wild-harvested marine or fungal sources. Sustainability credentials and sourcing practices differ; consumers should weigh cost against environmental and ethical considerations, particularly for omega-3s (fish oil vs algal sources) and certain herbal ingredients.

Common myths and red flags to ignore

• “Doctor-formulated” or celebrity endorsements equal efficacy. Credentials matter, but independent data do too.
• Proprietary blends hide dosages. Transparent labels listing ingredient amounts allow proper assessment.
• Bigger doses are better. Excess can cause harm; balance matters.
• “Natural” equals safe. Natural compounds can interact with drugs and produce toxicity.
• Quick fixes for complex problems. Supplements rarely substitute for evidence-based medical care, therapy or surgery when indicated.

A sensible supplementation roadmap you can follow

1. Audit your diet first. Improve food sources of vitamins and minerals—leafy greens, oily fish, fortified foods, whole grains and legumes.
2. Use targeted testing for suspected deficiencies (D, iron, B12, thyroid work-up where indicated).
3. Start with one or two evidence-backed supplements if tests or symptoms support them (e.g., vitamin D for low levels; iron for iron-deficiency anaemia).
4. Reassess after 3 months with symptom check and repeat tests as needed.
5. Add treatments only after reassessment and with an eye on interactions.
6. Maintain a stance of periodic review, not lifetime automatic dosing.

Real-world examples

Example 1: Correcting iron deficiency to restore function A woman in her 40s with heavy menses reports chronic fatigue and breathlessness on exertion. Blood tests reveal low ferritin and mild anaemia. Under supervision, she starts gentle oral iron replacement and improves energy and exercise tolerance within weeks. Her cardiologist notes that optimising iron status supports cardiovascular function and reduces hospitalisation risk in heart failure patients when deficiency exists.

Example 2: Magnesium improving sleep A middle-aged academic with sleep difficulty since menopause starts 200–300 mg evening magnesium glycinate. Over several weeks her sleep latency falls and subjective restfulness improves. She pairs the supplement with sleep hygiene measures and avoids stimulant intake late in the day.

Example 3: Vitamin D for bone health and immunity An older man with limited sun exposure measures low vitamin D in winter. He takes a clinician-recommended dose of vitamin D3, later found to normalise levels. He reports fewer winter colds and completes a bone-strengthening exercise class in parallel.

These are illustrations, not universal prescriptions. Clinical context, testing and supervision remain crucial.

Where the evidence needs to improve

High-quality, large-scale randomised controlled trials are missing for many popular supplements and niche formulas. The industry would benefit from:

• Standardised product formulations in trials for reproducibility.
• Long-term outcome data on morbidity and mortality, not just surrogate markers.
• Greater transparency on interactions and safety in polypharmacy settings.
• Independent funding and trial registries that counter conflict-of-interest bias in industry-sponsored research.

Clinicians and researchers continue to close these gaps. Consumers should follow emerging data while retaining a cautious posture toward bold claims.

FAQ

Q: Should everyone take a daily multivitamin? A: Not necessarily. Multivitamins can correct poor dietary intake and certain subclinical deficiencies, and some trials suggest modest benefits in older adults. For many people with balanced diets and no absorption issues, targeted testing and specific supplements for deficiencies are more cost-effective. If you choose a multivitamin, pick a product with clear dosages and avoid megadoses of fat-soluble vitamins unless directed by a clinician.

Q: Is vitamin D worth taking year-round in the UK? A: For many people, particularly those with limited sun exposure, darker skin, older age, or living at northern latitudes, year-round supplementation is reasonable. Seasonal dosing is an alternative, but testing guides the best approach. Vitamin D dosing should aim to correct low levels and maintain adequate status without excess.

Q: Can supplements help you live longer? A: No supplement guarantees longer life. Some interventions influence biomarkers associated with ageing and disease risk; a recent trial suggested a modest slowing of biological ageing with multivitamin use in older adults. Longevity interventions emphasise lifestyle: exercise, diet, sleep, smoking cessation and medical management of chronic disease remain the most reliable strategies.

Q: Are celebrity-backed supplements safe and effective? A: Celebrity endorsements increase visibility but do not substitute for clinical evidence. Evaluate products on the strength of peer-reviewed research, ingredient disclosure and third-party testing rather than celebrity association alone.

Q: Are there supplements to protect the brain? A: Addressing known deficits (B12, iron) and lifestyle factors is the most effective approach. Emerging data suggest certain compounds—creatine, omega-3s, and possibly specific mushrooms—may offer cognitive benefits in particular groups, but many marketed “brain blends” lack robust evidence. Discuss targeted strategies with a clinician if you have concerns about cognition.

Q: Can I take multiple supplements safely? A: Combination use requires caution. Mineral interactions (e.g., zinc and copper), vitamin K’s interaction with warfarin, and compounded effects on bleeding risk are examples. Maintain a list of all supplements and medications and review them with your clinician or pharmacist.

Q: How do I pick a reputable supplement brand? A: Look for transparency, independent third-party testing (e.g., USP, NSF, Informed-Sport), clear dosing, and no hidden proprietary blends. Avoid products that make disease-treatment claims. Check whether a company provides batch testing or certificates of analysis.

Q: What should pregnant people avoid? A: Certain vitamins (high-dose vitamin A) and many herbal supplements are contraindicated or untested in pregnancy. Prenatal vitamins formulated for pregnancy contain appropriate folic acid, iron and other nutrients; follow obstetric advice.

Q: Are herbal and mushroom products effective? A: Some have clinical support for narrow uses (ashwagandha for stress, reishi for immune markers, lion’s mane for preliminary cognitive signals), but variability in product quality and study design means evidence is less consistent than for essential nutrients. Use cautiously and consult a clinician before combining with medications.

Q: How often should I recheck blood levels after starting a supplement? A: For correcting deficiencies, reassess levels after an appropriate timeframe—often 8–12 weeks for vitamin D and iron—to ensure adequacy and safe dosing. For chronic supplements, periodic review (every 6–12 months) is sensible, or sooner if symptoms or medications change.

Q: Where can I get reliable guidance? A: Consult your GP, a registered dietitian, clinical pharmacist or relevant specialist. They can order tests, review medications, and tailor recommendations to your health status rather than relying on marketing.

British consumers face an abundant—and often confusing—market. The right supplements improve health when targeted to a measured need. The wrong ones waste money and can cause harm. Testing, clinical oversight and sceptical assessment of evidence are the best tools for separating lasting benefit from passing trends.